K152432 is an FDA 510(k) clearance for the ActiPatch(R). Classified as Nonthermal Shortwave Therapy Device Indicated For Over The Counter Use For The Treatment Of Pain (product code PQY), Class II - Special Controls.
Submitted by Bioelectronics Corporation (Frederick, US). The FDA issued a Cleared decision on February 3, 2017 after a review of 526 days - an unusually long review period, suggesting complex equivalence evaluation.
This device falls under the Physical Medicine FDA review panel, regulated under 21 CFR 890.5290 - the FDA physical medicine device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Physical Medicine submissions.
View all Bioelectronics Corporation devices